{"transactions":[{"id":963718,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-18T17:49:30.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-028394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315225028394/ownership.xml","form_type":"4"}},{"id":1324812,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options","published_at":"2024-12-20T20:33:14.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027."}],"balance_after":75000,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-051143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224051143/ownership.xml","form_type":"4"}},{"id":1575638,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options","published_at":"2024-03-15T20:00:10.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":false,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date."}],"balance_after":91666,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001493152-24-010168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224010168/ownership.xml","form_type":"4"}},{"id":1575637,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-15T20:00:10.000Z","date":"2024-03-13","kind":"sale","planned":false,"acquired":false,"shares":8334,"price":6.22,"value":51837.48,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-24-010168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224010168/ownership.xml","form_type":"4"}},{"id":1575636,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-15T20:00:10.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":true,"shares":8334,"price":3.59,"value":29919.06,"ownership":{"direct":true},"balance_after":8334,"source":{"system":"sec-edgar","filing":"0001493152-24-010168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224010168/ownership.xml","form_type":"4"}},{"id":1719454,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:05:59.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":100000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-23-044054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315223044054/ownership.xml","form_type":"4"}}]}